Atrium C-Qur Hernia Mesh Bellwether Trials May Be Pushed Back to Start in 2021

|

The U.S. District Judge presiding over all Atrium C-Qur hernia mesh lawsuits is considering whether to delay the start of the first bellwether trial until the beginning of next year, due to delays and disruptions caused by the ongoing coronavirus outbreak.

There are nearly 2,000 product liability lawsuits filed against Atrium Medical Corp. throughout the federal court system, each involving similar allegations that plaintiffs experienced problems with a hernia mesh systemย known as C-Qur (pronounced โ€œsecureโ€), which featured a unique polypropylene patch design with an an Omega-3 fatty acid (O3FA) gel coating.

While this design was intended to reduce scar tissue formation and promote fixation of the mesh to the abdominal wall, plaintiffs claim the C-Qur patch actually increased the risk of an inflammatory response, bowel adhesions and other painful complications, often resulting in additional surgery.

Is there a hernia mesh lawsuit? Find out if you qualify for a hernia mesh lawsuit settlement payout.
Is there a hernia mesh lawsuit? Find out if you qualify for a hernia mesh lawsuit settlement payout.

Given similar questions of fact and law raised in the complaints brought throughout the federal court system, the U.S. Judicial Panel on Multidistrict Litigation (JPML) establishedย consolidated pretrial proceedings for all Atrium C-Qur hernia mesh casesย in December 2016, centralizing the cases before U.S. District Judge Landya McCafferty in New Hampshire, for coordinating discovery, pretrial rulings and a โ€œbellwetherโ€ process, where a group of representative claims have been prepared for trial to help the parties gauge how juries may respond to certain evidence and testimony that is likely to be repeated throughout the cases.

Currently the first trial is scheduled to begin on May 20, and the parties have been discussing the potential for a new trial date as a result of disruptions to the judicial process caused by the COVID-19 pandemic, but have not yet reached an agreement.

In a motion (PDF) filed on April 8, Atrium asked the court to delay the start of the trial more than six months, pushing the case into January 2021 and extending all pretrial deadlines by about 90 days.

The manufacturer has asked for an expedited consideration of the motion, given the fast-approaching deadlines associated with the original trial date. Plaintiffs have been directed to file a response on or before April 16, and the Court has continued deadlines set for selecting the final trial cases that were supposed to be designated this week.

While the outcomes of these โ€œbellwetherโ€ trials will not be binding on other claims, the process is designed to facilitate potentialย hernia mesh settlementsย that may be necessary to avoid the need for hundreds of individual trials in various U.S. District Courts nationwide following the coordinated MDL proceedings.

Irvin Jackson
Written by: Irvin Jackson

Senior Legal Journalist & Contributing Editor

Irvin Jackson is a senior investigative reporter at AboutLawsuits.com with more than 30 years of experience covering mass tort litigation, environmental policy, and consumer safety. He previously served as Associate Editor at Inside the EPA and contributes original reporting on product liability lawsuits, regulatory failures, and nationwide litigation trends.

Image Credit: |



0 Comments


This field is for validation purposes and should be left unchanged.

Share Your Comments

This field is hidden when viewing the form
I authorize the above comments be posted on this page
Post Comment
Weekly Digest Opt-In

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

MORE TOP STORIES

A Massachusetts man has filed an Ozempic vision loss lawsuit claiming the diabetes drug injections caused a condition that eroded his vision in both eyes.
A public health advocacy group and two Pennsylvania men have filed a lawsuit against FanDuel, DraftKings and the NFL over the use of data for addictive, live in-game microbets.
Insulet is removing certain Omnipod 5 insulin pump pods from use following a surge in reports of insulin delivery failures that raise risks of diabetic ketoacidosis and other serious complications.